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Abstract Solid papillary carcinoma, a special form of breast carcinoma with neuroendocrine 
differentiation, usually presents in women aged 60 years or more. (Koern 2010). 
According to our best knowledge, we present the second case of such a tumor in 
pregnant women. 
CASE
In September of 2010, a 28-year-old Caucasian 
woman was referred to our center in her 31st week 
of first pregnancy. She developed a palpable mobile 
tumor in her lower internal quadrant of the left 
breast, 1.5 cm in diameter, which was diagnosed by 
her primary care obstetrician during a routine 3rd 
trimester breast clinical examination. Sonography 
revealed the nodule to have suspicious characteris-
tics. The lymph nodes in the left axillary fossa were 
unsuspected. 
The ultrasonography guided high-speed core 
biopsy of the lump revealed a DCIS of the breast. 
She was treated with lumpectomy and axillary 
lymph node resection in the 31st week of gestation.
The chormogranin A level initially was 
4.6 nmol/l, FT4 – 1.10 ng/dl, TSH – 0.8126 μIU/ml. 
Macroscopically, a well circumscribed tumour 
(Figure 1), 11 mm in diameter, was removed within 
a 40 × 30 × 20 mm breast tissue fragment. Based 
on histological and immunohistochemical studies, 
the diagnosis of solid papillary breast carcinoma 
with focal neuroendocrine immunophenotype 
was settled. Histological study revealed the neo-
plasm to be built of solid nests of atypical epithe-
lial cells (Figure 2), which were characterized by 
light or moderate polymorphism, mucin droplets 
in cytoplasm, and abundant mitotic activity. They 
presented a strong expression of cytokeratin CK7 
(Figure 3), and estrogen receptor (ER) in nearly 
all tumor cells. The reactions against progesterone 
receptor, chromogranin A (Figure 4), and Ki67 
protein gave positive results in 30%, 20% and 40% 
of neoplastic cells, respectively. There was no reac-
tion to HER2 receptor.
The personal and familial history of our patient 
was negative for breast cancer. At the time of eval-
uation, our patient was in good general condition. 
The obstetrical status was: a single fetus in cephalic 
presentation, the biophysical status of the fetus 
and uterus was adequate to gestational age with 
estimated fetal weight of 1 890 g; normal, Grade 2 
placenta attached to the posterior uterine wall with 
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a normal amount of amniotic fluid. The anatomy of the fetus, umbilical 
cord and placenta were within normal range. At 31 weeks of gestation, 
based on OGTT, she was diagnosed with Diabetes Type G/B (fasting 
glucose level – 7.34 mmol/l, and 8.06 mmol/l, 120 minutes after 75 g 
glucose load). The abdominal ultrasound examination revealed no 
pathology. The patient was treated with 3 injections of a rapid insulin 
analogue and 2 injections of isophane insulin. A metabolic wellness 
status was reached with diabetic diet (1 800 kcal/6 meals) and 22 units 
of insulin/24 hrs. She was diagnosed with Barlow syndrome and Wolf 
Parkinson White syndrome. 
She delivered at 36 +2 weeks of gestation vaginally. She delivered a 
healthy girl 3 060g/52 cm, 10 points of Apgar score. 
Our patient had SLN dissection on the ipsilateral axilla (4 nodes 
with maximum radioisotope signaling of 1100) – which were histo-
logically negative. The patient had axillary 
lymph nodes irradiated, and was region-
ally treated with Anthracycline-based 
chemotherapy concurrently with TAM 
hormone therapy. 
Our patient is in good health with a 
Performance Status 0 (ECOG). A thor-
ough examination (breast mammography, 
abdominal ultrasound, total-body com-
puterized tomography, bone scintigraphy, 
pelvic and transvaginal ultrasound and 
PET) showed no evidence of metastases.
DISCUSSION
Solid papillary carcinoma (SPC) is an 
uncommon breast neoplasm representing 
approximately 1–1.5% of breast malig-
nant tumours (Kuroda et al. 2010). It can 
be considered both as a distinctive form 
of papillary carcinoma (Hardisson et al. 
2003) as well as peculiar subtype of neu-
roendocrine breast carcinoma (Righi et 
al. 2010). According to WHO 2003 clas-
sification, SPC is a rare variant of intra-
ductal carcinoma (Otsuki et al. 2007); 
however most SPC cases do not present 
the immunohistochemical staining for 
myoepithelial markers in spite of a well-
circumscribed non-invasive histological 
appearance (Nicolas et al. 2007). Impor-
tantly, the ultrastructural studies did not 
reveal the presence of myoepithelial cells 
in the region of neoplastic cells (Dickersin 
et al. 1997). 
Solid papillary breast carcinomas are 
characterized by distinctive morphological 
and immunohistochemical features. They 
are composed of circumscribed large cel-
lular nodules, separated by bands of dense 
fibrosis (Otsuki et al. 2007). The tumor 
cells express a positive reaction to estrogen 
and progesterone receptors, as well as at 
least focal cytoplasmic positivity for chro-
mogranin A or synaptophysin (Wei et al. 
2006). Although neuroendocrine differ-
entiation is often described to be specific 
for SPC and many authors have stressed 
the importance of using special staining 
for neuroendocrine markers to differenti-
ate between SPC and other types of DCIS 
(Maluf & Koerner, 1995; Kanbayashi et al. 
2001), the positivity for neuroendocrine 
markers does not necessarily confirm a 
diagnosis of SPC (Otsuki et al. 2007). Yet 
some authors reported that a few cases do 
not exhibit neuroendocrine differentiation 
(Tsang & Chan 1996). 
Fig. 1. Well circumscribed tumour.
Fig. 2. Atypical epithelial cells.
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Solid papillary carcinoma of the breast 
tends to occur in older women. In the 
series of 58 cases of SPC, the mean age 
of patients was 72 years and in the other 
three reports presenting 20 cases each, 
the mean age of patients was 66 years 
(Otsuki et al. 2007; Wei et al. 2006). How-
ever, there are sporadic reports of a young 
female diagnosed even in their second 
decade of life (Jaffer et al. 2004). To our 
knowledge, there was only one case of 
SPC of the breast reported in a pregnant 
woman (Jaffer et al. 2004).
Follow-up data of few studies sug-
gested that SPC often carried an indolent 
clinical behaviour and favourable prog-
nosis (Otsuki et al. 2007; Wei et al. 2006). 
Lymph node metastases were uncom-
mon and generally limited to cases with 
coexisting invasive components (Nassar 
et al. 2006). Such an additional invasive 
component of SPC can consist of the his-
tological texture typical for invasive neu-
roendocrine cell carcinoma or mucinous 
carcinoma (Otsuki et al. 2007). Otsuki 
et al. reported a better prognosis of SPC 
even associated with invasive cancer. The 
5-year disease – free survival rate was 
93.4% and 83.0% for grade 1 and grade 
2 Breast Cancer. Since nothing is known 
about the prognosis of SPC diagnosed in 
pregnant women, a large-scale follow-up 
study would be of great value. 
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Fig. 3. Positive immunohistochemical reaction to cytokeratin 7.
Fig. 4. positive reaction to chromogranin A - magnif. 40×
